P53 Acts as a Co-Repressor to Regulate Keratin 14 Expression during Epidermal Cell Differentiation

Bi-He Cai,Chung-Faye Chao,Pei-Ching Hsu,Pao-Luh Tao,Shih-Hwa Chiou,Hwang-Chi Lin,I-Lun Hsin,Jang-Yi Chen,Mei-Hua Lu,Wei-Guo Zhu

doi:10.1371/journal.pone.0041742

Abstract

During epidermal cell differentiation, keratin 14 (K14) expression is down-regulated, p53 expression varies, and the expression of the p53 target genes, p21 and 14-3-3σ, increases. These trends suggest that the relative transcriptional activity of p53 is increased during epidermal cell differentiation. To determine the relationship between K14 and p53, we constructed K14 promoters of various sizes and found that wild-type p53 could repress the promoter activity of all of the K14 promoter constructs in H1299 cells. K14-p160 contains an SP1 binding site mutation that prevents p53 from repressing K14 expression. Using a DNA affinity precipitation assay, we confirmed that p53 forms a complex with SP1 at the SP1 binding site between nucleotides -48 and -43 on the K14 promoter. Thus, our data indicate that p53 acts as a co-repressor to down-regulate K14 expression by binding to SP1. Next, we used a 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced epidermal cell differentiation model to examine the inhibition of K14 expression caused by increased p53 activity. Human ovarian teratocarcinoma C9 cells were treated with TPA to induce differentiation. Over-expression of the dominant negative p53 mutant ΔTAp53, which inhibits p53 activity, prevented the TPA-induced K14 down-regulation in C9 cells. Furthermore, treatment of normal primary human foreskin keratinocytes (PHFK) with the p53 inhibitor pifithrin-α (PFT-α) showed that the inhibition of p53 activity relieves K14 repression during epidermal cell differentiation. Finally, we found that TPA induces the phosphorylation of p53 at residue 378, which enhances the affinity of p53 to bind to Sp1 and repress K14 expression.

Highlights

The transcription factor p53 is a tumor suppressor gene that regulates cell proliferation [1,2]
A ChIP assay revealed that Sp1 and p53 could occupy the proximal but not the distal region of the Keratin 14 (K14) promoter (Fig. 3E). These results suggest that p53 can associate with SP1 to bind to the SP1 binding site on the K14 promoter
When C9 cells were transfected with DTAp53 and were treated with TPA, p63 expression decreased, but the TPA-induced repression of K14 and the enhancement of p21 were reduced. (Fig. 4B and 4C). These results suggest that the active form of p53 induced by TPA represses K14 expression and increases p21 expression, and these effects can be reversed by the presence of a dominant negative p53 mutant

Summary

Introduction

The transcription factor p53 is a tumor suppressor gene that regulates cell proliferation [1,2]. Wild-type p53 and either p53 248 W or DTAp53 were co-transfected into H1299 cells to determine which p53 mutant had a larger dominant negative effect on K14 expression. These results suggest that the active form of p53 induced by TPA represses K14 expression and increases p21 expression, and these effects can be reversed by the presence of a dominant negative p53 mutant. Constitutively phosphorylated p53 mimic p53 378D was able to bind SP1 significantly more than the unphosphorylatable p53 378A mutant when overexpressed in H1299 cells (Fig. 7B) These results suggest that TPA promotes the phosphorylation of p53 at residue 378, which could promote the p53 and Sp1 protein-protein interaction. These results suggest that knocking down p53 reverses TPAmediated K14 repression

Discussion

Findings

Materials and Methods